AzTrials
AzTrials

Endodontically Treated TeethNCT07465978

Clinical Performance of Printed Hybrid Resin in Indirect Restorations

A study testing Indirect adhesive overlay restoration, Enamel Plus HRi and RelyX Universal in people with Endodontically Treated Teeth and Indirect Restoration, run by Universitat Internacional de Catalunya at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized clinical trial aims to evaluate the clinical performance of a 3D-printed hybrid resin (VarseoSmile TriniQ) used for indirect restorations in endodontically treated teeth, compared with a CAD/CAM composite block (Cerasmart). Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Indirect adhesive overlay restoration, Enamel Plus HRi and RelyX Universal
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSpain
Study dates
13 Dec 2024to 1 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥18 years
  • Signed informed consent
  • Need to restore an endodontically treated molar with an indirect adhesive overlay
  • Physically and psychologically able to tolerate conventional restorative procedures
  • No high caries risk
  • No active periodontal disease
Show all 11Show fewer
  • Natural antagonist tooth present
  • Need for full cuspal coverage restoration (overlay)
  • Remaining wall thickness <3 mm in the endodontically treated tooth
  • Occlusal thickness of the restoration ≥1 mm
  • Willing and able to attend follow-up visits

Who cannot join

  • Poor oral hygiene
  • Uncontrolled parafunctional habits (e.g., bruxism)
  • High caries risk
  • Active periodontal disease
  • Active pulpal disease
  • Absence of natural antagonist tooth
Show all 10Show fewer
  • Need for partial cuspal coverage restoration (inlay or onlay)
  • Insufficient interarch space for restoration
  • Teeth planned as abutments for removable or fixed prostheses
  • Known allergy to any materials used in the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

MARTA VALLES, DDS, PhD contact

+34619747903

mvalles@uic.es

Patricia Freire, DDS contact

patricia.freire@uic.es

Spain1 site, 1 recruiting
  • Clínica Universitària d'Odontologia UIC Barcelona

    Sant Cugat del Vallès, Barcelona, 08195

    MARTA VALLES, Principal Investigator, 619747903, mvalles@uic.es

    PATRICIA FREIRE, Sub Investigator, patricia.freire@uic.es

    Recruiting

Other trials in Spain

About this study

Official title: Clinical Behavior of 3D-Printed VarseoSmile TriniQ Resin Versus CAD/CAM Cerasmart in Indirect Restorations for Endodontically Treated Teeth: A Randomized Clinical Trial

This randomized clinical trial aims to evaluate the clinical performance of a 3D-printed hybrid resin (VarseoSmile TriniQ) used for indirect restorations in endodontically treated teeth, compared with a CAD/CAM composite block (Cerasmart). In addition, two different luting protocols will be compared: a preheated microhybrid composite (Enamel Plus HRi) and a resin cement (RelyX Universal).

Sixty patients requiring restoration of an endodontically treated molar with an indirect adhesive overlay will be recruited at the University Dental Clinic of the Universitat Internacional de Catalunya (Barcelona, Spain). Participants will be randomly assigned to receive restorations fabricated either using the printed hybrid resin or the CAD/CAM composite material. Each material group will be further divided according to the cementation technique used.

Read more

All restorations will be fabricated following a digital workflow that includes intraoral scanning, CAD design, and either additive manufacturing (3D printing) or subtractive milling. Adhesive luting procedures will be performed according to standardized clinical protocols.

Clinical evaluations will be performed at baseline, 3 months, 6 months, and 12 months, and annually thereafter. The clinical performance of the restorations will be assessed using modified United States Public Health Service (USPHS) criteria, including parameters such as marginal adaptation, contact points, color stability, wear, fracture occurrence, secondary caries, and patient comfort.

The results of this study will provide clinical evidence regarding the behavior of 3D-printed hybrid resin restorations and their potential use as an alternative to conventional CAD/CAM composite materials for indirect restorations in endodontically treated teeth.

Read the detailed description

Digital dentistry has significantly evolved over recent decades with the development of computer-aided design and computer-aided manufacturing (CAD/CAM) technologies. These digital workflows allow the design and fabrication of indirect restorations with high precision and efficiency. Traditionally, most CAD/CAM restorations have been produced using subtractive manufacturing techniques such as milling. However, additive manufacturing through three-dimensional printing is increasingly being introduced in dentistry and may offer advantages such as reduced material waste, lower manufacturing costs, and the ability to fabricate complex geometries.

Recently, a hybrid ceramic-filled resin specifically designed for additive manufacturing of definitive restorations has been introduced (VarseoSmile TriniQ, BEGO, Bremen, Germany). This material consists of a resin matrix filled with ceramic particles and is indicated for permanent restorations including crowns, inlays, onlays, and veneers. Although promising, clinical evidence regarding the performance of this printed hybrid material is still limited.

Composite CAD/CAM blocks such as Cerasmart (GC, Tokyo, Japan) are widely used for indirect restorations due to their favorable mechanical properties, wear resistance, and reparability. These materials combine characteristics of ceramics and composites and have demonstrated good clinical performance in previous studies. However, it remains unclear whether the newer printed hybrid materials provide comparable clinical outcomes.

Another important factor influencing the longevity of indirect restorations is the luting procedure. Preheated restorative composite resins have been proposed as an alternative to traditional resin cements for adhesive luting of indirect restorations. This technique may improve mechanical properties and reduce marginal gaps, but clinical evidence comparing these approaches remains limited.

The aim of this randomized clinical trial is therefore to evaluate the clinical behavior of indirect overlay restorations fabricated with a 3D-printed hybrid resin (VarseoSmile TriniQ) compared with restorations fabricated from a CAD/CAM composite block (Cerasmart). Additionally, two cementation strategies will be evaluated: a preheated microhybrid composite resin (Enamel Plus HRi) and a resin cement (RelyX Universal).

A total of 60 patients requiring restoration of an endodontically treated molar with an indirect overlay will be recruited at the University Dental Clinic of the Universitat Internacional de Catalunya (Barcelona, Spain). Participants will be randomly allocated into four groups according to the restorative material and cementation protocol used.

All teeth will receive standardized preparation procedures for adhesive indirect overlays, including immediate dentin sealing when indicated. Restorations will be designed using CAD software and fabricated either by additive manufacturing (3D printing) or subtractive milling. Adhesive luting will be performed following standardized protocols using rubber dam isolation.

Clinical evaluations will be performed at baseline, 3 months, 6 months, and 12 months, and annually thereafter. Outcomes will be assessed using modified United States Public Health Service (USPHS) criteria. The evaluated parameters will include marginal adaptation, contact points, color stability, polishability, wear, fracture occurrence, secondary caries, and patient comfort.

The results of this study are expected to provide new clinical evidence regarding the performance of 3D-printed hybrid resin restorations and the influence of different luting protocols in indirect restorations of endodontically treated teeth.

Being tested
Indirect adhesive overlay restoration, Enamel Plus HRi, RelyX Universal, VarseoSmile TriniQ (3D-printed hybrid resin), Cerasmart (CAD/CAM composite block)
Keywords
Indirect restoration, CAD-CAM dentistry, 3D printing dentistry, Hybrid resin restoration, Overlay restoration, Digital dentistry, VarseoSmile TriniQ, cerasmart
Medical subject headings
Tooth, Nonvital

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indirect adhesive overlay restorationProcedure or surgery

    Indirect overlay restoration performed on endodontically treated molars following a standardized digital workflow including tooth preparation, intraoral scanning, CAD design, and fabrication using either a 3D-printed hybrid resin (VarseoSmile TriniQ) or a CAD/CAM composite block (Cerasmart). Adhesive cementation is performed under rubber dam isolation.

  • Enamel Plus HRiDevice

    Preheated microhybrid composite resin used as a luting material for indirect restorations. The composite is preheated to improve flowability and used as an adhesive luting agent following a standardized clinical protocol.

  • RelyX UniversalDevice

    Resin cement used for adhesive luting of indirect restorations according to the manufacturer's instructions and standardized clinical protocol.

  • VarseoSmile TriniQ (3D-printed hybrid resin)Device

    Definitive indirect overlay fabricated using the 3D-printed hybrid resin VarseoSmile TriniQ (BEGO) following manufacturer-recommended printing and post-curing procedures.

  • Cerasmart (CAD/CAM composite block)Device

    Definitive indirect overlay fabricated from the CAD/CAM resin-composite block Cerasmart (GC) using a standardized milling and finishing protocol.

Study groups in NCT07465978
Study groupRoleWhat they receive
VarseoSmile TriniQ + Enamel Plus HRiExperimentalIndirect overlay restoration fabricated using the 3D-printed hybrid resin VarseoSmile TriniQ and adhesively luted using a preheated microhybrid composite (Enamel Plus HRi) following a standardized clinical protocol.
Receives: Procedure: Indirect adhesive overlay restoration; Device: Enamel Plus HRi; Device: VarseoSmile TriniQ (3D-printed hybrid resin)
VarseoSmile TriniQ + RelyX UniversalExperimentalIndirect overlay restoration fabricated using the 3D-printed hybrid resin VarseoSmile TriniQ and adhesively luted using the resin cement RelyX Universal following a standardized clinical protocol.
Receives: Procedure: Indirect adhesive overlay restoration; Device: RelyX Universal; Device: VarseoSmile TriniQ (3D-printed hybrid resin)
Cerasmart + Enamel Plus HRiActive comparatorIndirect overlay restoration fabricated using the CAD/CAM composite block Cerasmart and adhesively luted using a preheated microhybrid composite (Enamel Plus HRi) following a standardized clinical protocol.
Receives: Procedure: Indirect adhesive overlay restoration; Device: Enamel Plus HRi; Device: Cerasmart (CAD/CAM composite block)
Cerasmart + RelyX UniversalActive comparatorIndirect overlay restoration fabricated using the CAD/CAM composite block Cerasmart and adhesively luted using the resin cement RelyX Universal following a standardized clinical protocol.
Receives: Procedure: Indirect adhesive overlay restoration; Device: RelyX Universal; Device: Cerasmart (CAD/CAM composite block)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical success of indirect overlay restorations

    Clinical success of indirect overlay restorations placed on endodontically treated molars assessed using the modified United States Public Health Service (USPHS) criteria. Each restoration will be evaluated for marginal adaptation, contact points, color stability, wear, fracture, and secondary caries. USPHS scores are classified as Alpha (ideal clinical condition), Bravo (clinically acceptable), or Charlie (clinically unacceptable requiring replacement). Comparisons will be performed between restorative materials (3D-printed hybrid resin VarseoSmile TriniQ and CAD/CAM composite Cerasmart) and between luting protocols (preheated microhybrid composite Enamel Plus HRi and resin cement RelyX Universal).

    Measured: Baseline, 3 months, 6 months, and 12 months after restoration placement.

Secondary outcomes (8)
  1. Marginal adaptation of the restoration

    Assessment of marginal adaptation of the indirect restoration using modified USPHS criteria during follow-up examinations. Scores will be classified according to modified USPHS criteria (Alpha = ideal, Bravo = clinically acceptable, Charlie = clinically unacceptable).

    Measured: Baseline, 3 months, 6 months, and 12 months after restoration placement.

  2. Proximal contact stability

    Evaluation of proximal contact points between the restoration and adjacent teeth during follow-up visits. Scores will be classified according to modified USPHS criteria (Alpha = ideal, Bravo = clinically acceptable, Charlie = clinically unacceptable).

    Measured: Baseline, 3 months, 6 months, and 12 months after restoration placement.

  3. Color stability of the restoration

    Clinical assessment of color match and color stability of the restoration during follow-up using modified USPHS criteria. Scores will be classified according to modified USPHS criteria (Alpha = ideal, Bravo = clinically acceptable, Charlie = clinically unacceptable).

    Measured: Baseline, 3 months, 6 months, and 12 months after restoration placement.

  4. Wear of the restoration

    Evaluation of occlusal wear of the restoration during clinical follow-up using modified USPHS criteria. Scores will be classified according to modified USPHS criteria (Alpha = ideal, Bravo = clinically acceptable, Charlie = clinically unacceptable).

    Measured: Baseline, 3 months, 6 months, and 12 months after restoration placement.

  5. Restoration fracture or chipping

    Assessment of the presence of fractures or chipping of the indirect restoration during follow-up examinations. Scores will be classified according to modified USPHS criteria (Alpha = ideal, Bravo = clinically acceptable, Charlie = clinically unacceptable).

    Measured: Baseline, 3 months, 6 months, and 12 months after restoration placement.

  6. Secondary caries adjacent to the restoration

    Detection of caries adjacent to restoration margins during clinical follow-up visits. Scores will be classified according to modified USPHS criteria (Alpha = ideal, Bravo = clinically acceptable, Charlie = clinically unacceptable).

    Measured: Baseline, 3 months, 6 months, and 12 months after restoration placement.

  7. Patient-reported comfort with the restoration

    Assessment of patient-reported comfort and satisfaction with the indirect restoration during follow-up visits. Scores will be classified according to modified USPHS criteria (Alpha = ideal, Bravo = clinically acceptable, Charlie = clinically unacceptable).

    Measured: Baseline, 3 months, 6 months, and 12 months after restoration placement.

  8. Restoration survival

    Survival of the indirect overlay restoration during follow-up. A restoration will be considered a failure if it requires replacement due to fracture, debonding, secondary caries, unacceptable marginal adaptation, or any other clinical complication preventing proper function.

    Measured: From restoration placement to 12 months after placement.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2026
  2. Study start13 Dec 2024
  3. Primary completion1 Jun 2026 (estimated)
  4. Study completion1 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Model description
This study follows a 2×2 factorial randomized design. Participants requiring restoration of an endodontically treated molar with an indirect overlay will be randomly allocated to receive restorations fabricated using one of two restorative materials (3D-printed hybrid resin VarseoSmile TriniQ or CAD/CAM composite Cerasmart). Each material group will be further randomized according to the luting protocol used (preheated microhybrid composite Enamel Plus HRi or resin cement RelyX Universal), resulting in four study groups.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07465978
Sponsor's protocol ID
REST-ECL-2024-06
Status last verified
Mar 2026
First submitted
6 Mar 2026
Last updated
16 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be made publicly available due to institutional data protection policies and patient confidentiality considerations.

Questions about this trial

What is this clinical trial studying?

A study testing Indirect adhesive overlay restoration, Enamel Plus HRi and RelyX Universal in people with Endodontically Treated Teeth and Indirect Restoration, run by Universitat Internacional de Catalunya at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact MARTA VALLES, DDS, PhD (+34619747903, mvalles@uic.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical success of indirect overlay restorations (time frame: Baseline, 3 months, 6 months, and 12 months after restoration placement.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in